Detalles de la búsqueda
1.
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.
Clin Cancer Res
; 30(1): 74-81, 2024 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535056
2.
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.
Clin Lung Cancer
; 13(1): 31-8, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21862415
3.
Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy.
J Thorac Oncol
; 7(6): 1041-8, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22534814
4.
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.
J Clin Oncol
; 28(6): 911-7, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20100966
Resultados
1 -
4
de 4
1
Próxima >
>>